Critical Care
RSSArticles
-
Hyperbaric Oxygen for Carbon Monoxide Poisoning
-
Magnesium Sulfate for Acute Severe Asthma
-
Effects of Adding an Acute Care Nurse Practitioner to the Neuroscience Care Team
-
Critical Care Plus: Grants Focus on Improving Nursing Skills
-
Critical Care Plus: Using ‘Travelers’ to Meet Staffing Needs is Harder in ICUs
-
Full May 2003 Issue in PDF
-
Trauma Reports Supplement: From Stingers to Fangs - Evaluating and Managing Bites and Envenomations
Whether a bite or sting results in an anaphylactic reaction, impressive local effects, or a life-threatening systemic reaction, the emergency physician must be able to institute appropriate and effective treatment. Emergency physicians also must be able to recognize clinical envenomation patterns, since some critically ill patients may not be able to convey the details of the attack. Since all areas of the country are represented in the envenomation statistics, all emergency physicians should be familiar with identification and stabilization of envenomated patients and know what resources are available locally for further management of these often complicated patients. -
Beat the Heat: Recognizing and Managing Pediatric Heat-Related Illness
Since 1996, at least 150 children have died as a result of being trapped in hot, parked vehicles. Contrary to what would be expected, these deaths occurred throughout all regions of the United States, making it important for all emergency medicine physicians to be familiar with the resuscitation of a child with a heat-related illness. This article provides an overview of heat-related illnesses in children and prevention and management strategies to facilitate care. -
Full May 5, 2003, Issue in PDF
-
Urinary Tract Infection: Risk Stratification, Clinical Evaluation, and Evidence-Based Antibiotic Therapy, Part II
This issue is the second and final part in our series on urinary tract infection. Part I of the series examined epidemiology, emerging resistance patterns, and patient-specific treatment strategies. In part II, we will cover antibiotic selection, new treatment options, and special considerations.